News

Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a ...
A small pilot study published in the journal Psychedelic Medicine suggests that psilocybin-assisted psychotherapy might help ...
New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.
A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...
The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...
Psilocybin, a psychedelic compound once primarily known as a party drug, is increasingly being recognised for its medical ...
Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...
Iowa Gov. Kim Reynolds vetoed legislation last week that would’ve allowed doctors to prescribe synthetic psilocybin in Iowa ...
New Zealand has approved the medicinal use of psilocybin, a hallucinogenic compound found in magic mushrooms, to treat ...
A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...
New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...
New Zealand today approved the medicinal use of psilocybin, a hallucinogenic compound notably found in so-called “magic ...